Skip to main content
. 2020 Sep 24;56(10):501. doi: 10.3390/medicina56100501

Table 1.

Characteristics of the study population.

Total (n = 10,827) Non-Hyperuricemic (n = 9519) Hyperuricemic (n = 1308) p Regular HR (n = 10,697) Irregular HR (n = 130) p
Age, years 46.6 ± 0.3 47.0 ± 0.3 44.4 ± 0.6 <0.0001 46.5 ± 0.3 62.2 ± 1.9 <0.0001
Sex, male 50.0 (0.5) 45.9 (0.5) 76.6 (1.3) <0.0001 49.9 (0.5) 62.8 (5.2) 0.0072
Urban residence 85.1 (1.7) 85.0 (1.7) 85.9 (1.9) 0.5320 85.1 (1.7) 88.4 (2.9) 0.2678
Occupation 64.8 (0.7) 64.4 (0.7) 67.4 (1.7) 0.0789 64.9 (0.7) 52.0 (5.4) 0.0139
Income (lowest quartile) 15.1 (0.7) 15.1 (0.7) 15.2 (1.3) 0.9276 15.1 (0.7) 24.2 (4.2) 0.0090
Low education level a 23.0 (0.8) 23.5 (0.8) 19.6 (1.3) 0.0011 22.8 (0.8) 44.6 (4.9) <0.0001
Smoking <0.0001 <0.0001
    Never 59.4 (0.6) 61.8 (0.6) 43.7 (1.6) 59.6 (0.6) 43.4 (5.2)
    Former 19.0 (0.4) 18.2 (0.4) 24.3 (1.4) 18.8 (0.4) 41.2 (5.1)
    Current 21.6 (0.6) 20.0 (0.6) 32.0 (1.5) 21.6 (0.6) 15.4 (4.6)
Alcohol consumption <0.0001 0.1677
    None 22.1 (0.6) 23.1 (0.6) 15.9 (1.1) 22.1 (0.6) 29.9 (4.9)
    <30 g/day 68.7 (0.6) 68.8 (0.6) 67.8 (1.5) 68.7 (0.6) 63.5 (5.3)
    ≥30 g/day 9.2 (0.3) 8.1 (0.3) 16.4 (1.3) 9.3 (0.3) 6.6 (2.5)
Physical activity b 47.6 (0.7) 47.0 (0.7) 51.7 (1.7) 0.0062 47.6 (0.7) 45.1 (5.6) 0.6466
BMI, kg/m2 23.9 ± 0.1 23.6 ± 0.1 25.9 ± 0.1 <0.0001 24.0 ± 0.1 23.7 ± 0.3 0.4654
WC, cm 82.2 ± 0.2 81.3 ± 0.2 88.3 ± 0.3 <0.0001 82.2 ± 0.2 84.1 ± 0.9 0.0301
HR, per minute 57.6 ± 0.6 57.2 ± 0.6 60.0 ± 2.1 0.1980 55.9 ± 0.6 68.5 ± 1.5 <0.0001
HR irregularity 1.0 (0.1) 0.8 (0.1) 2.1 (0.5) <0.0001
Systolic BP, mmHg 117.5 ± 0.2 116.9 ± 0.2 121.8 ± 0.5 <0.0001 117.5 ± 0.2 122.1 ± 1.6 0.0043
Diastolic BP, mmHg 75.9 ± 0.2 75.4 ± 0.2 79.4 ± 0.4 <0.0001 76.0 ± 0.2 73.0 ± 1.0 0.0034
Fasting glucose, mg/dL 99.5 ± 0.3 99.4 ± 0.3 100.5 ± 0.6 0.0720 99.5 ± 0.3 107.2 ± 3.3 0.0198
Total C, mg/dL 193.5 ± 0.5 192.3 ± 0.5 201.3 ± 1.4 <0.0001 193.6 ± 0.5 180.5 ± 3.6 0.0003
TG c, mg/dL 112.4 (110.7–114.1) 106.9 (105.3–108.5) 155.8 (148.6–163.3) <0.0001 112.4 (110.7–114.1) 109.8 (98.3–122.6) 0.6756
eGFR d, mL/min/1.73m2 96.5 ± 0.3 97.7 ± 0.3 88.3 ± 0.6 <0.0001 96.6 ± 0.3 83.1 ± 2.4 <0.0001
Uric acid, mg/dL 5.14 ± 0.02 4.77 ± 0.01 7.53 ± 0.03 <0.0001 5.13 ± 0.02 5.66 ± 0.19 0.0072
hs-CRP, mg/dL 1.18 ± 0.02 1.12 ± 0.02 1.55 ± 0.07 <0.0001 1.17 ± 0.02 1.71 ± 0.34 0.1139
Obesity e 34.9 (0.6) 31.6 (0.7) 56.4 (1.6) <0.0001 34.9 (0.6) 35.9 (4.6) 0.8276
Abdominal obesity f 28.3 (0.7) 25.5 (0.7) 47.0 (1.6) <0.0001 28.3 (0.7) 32.7 (4.8) 0.3307
Hyperuricemia 13.2 (0.4) 13.1 (0.4) 29.5 (5.3) <0.0001
Hypertension 26.9 (0.6) 25.1 (0.6) 38.4 (1.7) <0.0001 26.7 (0.6) 51.4 (5.1) <0.0001
Diabetes mellitus 10.4 (0.4) 10.3 (0.4) 10.6 (1.0) 0.7933 10.2 (0.4) 22.1 (3.9) <0.0001
Hyperlipidemia 20.0 (0.5) 19.5 (0.5) 23.6 (1.4) 0.0032 20.0 (0.5) 18.3 (3.7) 0.6596
Chronic kidney disease 2.2 (0.2) 1.3 (0.1) 7.9 (0.7) <0.0001 2.1 (0.2) 11.2 (3.1) <0.0001
Cardiovascular disease 3.5 (0.2) 3.6 (0.2) 3.1 (0.5) 0.3184 3.4 (0.2) 15.9 (3.0) <0.0001

Data are presented as weighted mean ± standard error (SE) or weighted percentage (SE). a Low education level means middle school graduate or less. b Physical activity refers to more than 150 min of moderate-intensity aerobic physical activity throughout the week, or more than 75 min of vigorous-intensity aerobic physical activity throughout the week, or an equivalent combination of moderate- and vigorous-intensity activity. c TG values are presented as a geometric mean (95% confidence interval). d An eGFR calculated from serum creatinine using an isotope dilution mass spectrometry (IDMS) traceable Modification of Diet in Renal Disease (MDRD) Study equation. e Obesity is defined as a BMI ≥25 kg/m2. f Abdominal obesity is defined as a WC >90 cm in men or >85 cm in women. Abbreviations: HR, heart rate; BMI, body mass index; WC, waist circumference; BP, blood pressure; C, cholesterol; TG, triglyceride; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein.